Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vina-GPU 2.1: towards further optimizing docking speed and precision of AutoDock Vina and its derivatives

View through CrossRef
AbstractAutoDock Vina and its derivatives have established themselves as a prevailing pipeline for virtual screening in contemporary drug discovery. Our Vina-GPU method leverages the parallel computing power of GPUs to accelerate AutoDock Vina, and Vina-GPU 2.0 further enhances the speed of AutoDock Vina and its derivatives. Given the prevalence of large virtual screens in modern drug discovery, the improvement of speed and accuracy in virtual screening has become a longstanding challenge. In this study, we propose Vina-GPU 2.1, aimed at enhancing the docking speed and precision of AutoDock Vina and its derivatives through the integration of novel algorithms to facil-itate improved docking and virtual screening outcomes. Building upon the foundations laid by Vina-GPU 2.0, we introduce a novel algorithm, namely Reduced Iteration and Low Complexity BFGS (RILC-BFGS), designed to expedite the most time-consuming operation. Additionally, we implement grid cache optimization to further enhance the docking speed. Furthermore, we employ optimal strategies to individually optimize the structures of ligands, receptors, and binding pockets, thereby enhancing the docking precision. To assess the performance of Vina-GPU 2.1, we conduct extensive virtual screening experiments on three prominent targets, utilizing two fundamental compound libraries and seven docking tools. Our results demonstrate that Vina-GPU 2.1 achieves an average 4.97-fold acceleration in docking speed and an average 342% improvement in EF1% compared to Vina-GPU 2.0. The source code and tools for Vina-GPU 2.1 are freely available athttps://github.com/DeltaGroupNJUPT/Vina-GPU-2.1, accompanied by comprehensive instructions and illustrative examples.
Title: Vina-GPU 2.1: towards further optimizing docking speed and precision of AutoDock Vina and its derivatives
Description:
AbstractAutoDock Vina and its derivatives have established themselves as a prevailing pipeline for virtual screening in contemporary drug discovery.
Our Vina-GPU method leverages the parallel computing power of GPUs to accelerate AutoDock Vina, and Vina-GPU 2.
0 further enhances the speed of AutoDock Vina and its derivatives.
Given the prevalence of large virtual screens in modern drug discovery, the improvement of speed and accuracy in virtual screening has become a longstanding challenge.
In this study, we propose Vina-GPU 2.
1, aimed at enhancing the docking speed and precision of AutoDock Vina and its derivatives through the integration of novel algorithms to facil-itate improved docking and virtual screening outcomes.
Building upon the foundations laid by Vina-GPU 2.
0, we introduce a novel algorithm, namely Reduced Iteration and Low Complexity BFGS (RILC-BFGS), designed to expedite the most time-consuming operation.
Additionally, we implement grid cache optimization to further enhance the docking speed.
Furthermore, we employ optimal strategies to individually optimize the structures of ligands, receptors, and binding pockets, thereby enhancing the docking precision.
To assess the performance of Vina-GPU 2.
1, we conduct extensive virtual screening experiments on three prominent targets, utilizing two fundamental compound libraries and seven docking tools.
Our results demonstrate that Vina-GPU 2.
1 achieves an average 4.
97-fold acceleration in docking speed and an average 342% improvement in EF1% compared to Vina-GPU 2.
The source code and tools for Vina-GPU 2.
1 are freely available athttps://github.
com/DeltaGroupNJUPT/Vina-GPU-2.
1, accompanied by comprehensive instructions and illustrative examples.

Related Results

Vina-GPU 2.0:further accelerating AutoDock Vina and its derivatives with GPUs
Vina-GPU 2.0:further accelerating AutoDock Vina and its derivatives with GPUs
Modern drug discovery typically faces large virtual screens from huge compound databases where multiple docking tools are involved for meeting various real scenes or improving the ...
Accelerating AutoDock VINA with GPUs
Accelerating AutoDock VINA with GPUs
AutoDock Vina is one of the most popular molecular docking tools. In the latest benchmark CASF-2016 for comparative assessment of scoring functions, AutoDock Vina won the best dock...
Accelerating AutoDock VINA with GPUs
Accelerating AutoDock VINA with GPUs
AutoDock Vina is one of the most popular molecular docking tools. In the latest benchmark CASF-2016 for comparative assessment of scoring functions, AutoDock Vina won the best dock...
Accelerating AutoDock VINA with GPUs
Accelerating AutoDock VINA with GPUs
AutoDock VINA is one of the most-used docking tools in the early stage of modern drug discovery. It uses a Monte-Carlo based iterated search method and multithreading parallelism s...
Accelerating AutoDock VINA with GPUs
Accelerating AutoDock VINA with GPUs
AutoDock VINA is one of the most-used docking tools in the early stage of modern drug discovery. It uses a Monte-Carlo based iterated search method and multithreading parallelism s...
Improving the Accuracy of AutoDock Vina by Changing the Empirical Parameters
Improving the Accuracy of AutoDock Vina by Changing the Empirical Parameters
According to the previous benchmark, Autodock Vina (Vina) achieved a very high successful-docking rate, p ̂, but give a rather a low correlation coefficient, R, for binding affinit...
Improving Ligand-Ranking of AutoDock Vina by Changing the Empirical Parameters
Improving Ligand-Ranking of AutoDock Vina by Changing the Empirical Parameters
AutoDock Vina (Vina) achieved a very high docking-success rate, p ̂, but give a rather low correlation coefficient, R, for binding affinity with respect to experiments. This low co...
Docking Molecular analysis of potential Drug Paritaprevir against Mycobacterium tuberculosis (Mtb)
Docking Molecular analysis of potential Drug Paritaprevir against Mycobacterium tuberculosis (Mtb)
AbstractBackgroundMycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, which kills 1.8 million annually. This is an infectious disease generally affects the lun...

Back to Top